|
1
|
Filho AM, Laversanne M, Ferlay J, Colombet
M, Piñeros M, Znaor A, Parkin DM, Soerjomataram I and Bray F: The
GLOBOCAN 2022 cancer estimates: Data sources, methods, and a
snapshot of the cancer burden worldwide. Int J Cancer.
156:1336–1346. 2025.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chavez-MacGregor M, Mittendorf EA, Clarke
CA, Lichtensztajn DY, Hunt KK and Giordano SH: Incorporating tumor
characteristics to the American joint committee on cancer breast
cancer staging system. Oncologist. 22:1292–1300. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yu X, Li W, Sun S and Li J: Endoplasmic
reticulum stress in cancer progression: A comprehensive review of
its role and mechanisms. Int J Med Sci. 22:4561–4585.
2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ghemrawi R, Kremesh S, Mousa WK and Khair
M: The Role of ER stress and the unfolded protein response in
cancer. Cancer Genomics Proteomics. 22:363–381. 2025.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Çakmak E and Bilgici B: The relationship
between cancer and endoplasmic reticulum stress-induced apoptosis.
Kırıkkale Üni Tıp Derg. 27:111–119. 2025.
|
|
8
|
Ding L, Yan J, Zhu J, Zhong H, Lu Q, Wang
Z, Huang C and Ye Q: Ligand-independent activation of estrogen
receptor alpha by XBP-1. Nucleic Acids Res. 31:5266–5274.
2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Scriven P, Coulson S, Haines R,
Balasubramanian S, Cross S and Wyld L: Activation and clinical
significance of the unfolded protein response in breast cancer. Br
J Cancer. 101:1692–1698. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kiang JG, Gist ID and Tsokos GC: 17
beta-estradiol-induced increases in glucose-regulated protein 78kD
and 94kD protect human breast cancer T47-D cells from thermal
injury. Chin J Physiol. 40:213–219. 1997.PubMed/NCBI
|
|
11
|
Chen X, Iliopoulos D, Zhang Q, Tang Q,
Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y, et
al: Xbp1 promotes triple-negative breast cancer by controlling the
hif1alpha pathway. Nature. 508:103–107. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhao N, Cao J, Xu L, Tang Q, Dobrolecki
LE, Lv X, Talukdar M, Lu Y, Wang X, Hu DZ, et al: Pharmacological
targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven
breast cancer. J Clin Invest. 128:1283–1299. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Cano-González A, Mauro-Lizcano M,
Iglesias-Serret D, Gil J and López-Rivas A: Involvement of both
caspase-8 and Noxa-activated pathways in endoplasmic reticulum
stress-induced apoptosis in triple-negative breast tumor cells.
Cell Death Dis. 9(134)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhou W, Fang H, Wu Q, Wang X, Liu R, Li F,
Xiao J, Yuan L, Zhou Z, Ma J, et al: Ilamycin E, a natural product
of marine actinomycete, inhibits triple-negative breast cancer
partially through ER stress-CHOP-Bcl-2. Int J Biol Sci.
15:1723–1732. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dávila-González D, Choi DS, Rosato RR,
Granados-Principal SM, Kuhn JG, Li WF, Qian W, Chen W, Kozielski
AJ, Wong H, et al: Pharmacological inhibition of NOS Activates
ASK1/JNK pathway augmenting docetaxel-mediated apoptosis in
triple-negative breast cancer. Clin Cancer Res. 24:1152–1162.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Martín-Pérez R, Palacios C, Yerbes R,
Cano-González A, Iglesias-Serret D, Gil J, Reginato MJ and
López-Rivas A: Activated ERBB2/HER2 licenses sensitivity to
apoptosis upon endoplasmic reticulum stress through a
PERK-dependent pathway. Cancer Res. 74:1766–1777. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Benner SE and Hong WK: Clinical
chemoprevention: Developing a cancer prevention strategy. J Natl
Cancer Inst. 85:1446–1447. 1993.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Campbell KJ and Tait SWG: Targeting BCL-2
regulated apoptosis in cancer. Open Biol. 8(180002)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen X and Cubillos-Ruiz JR: Endoplasmic
reticulum stress signals in the tumour and its microenvironment.
Nat Rev Cancer. 21:71–88. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nathan DM, Buse JB, Davidson MB,
Ferrannini E, Holman RR, Sherwin R and Zinman B: American Diabetes
Association; European Association for Study of Diabetes. Medical
management of hyperglycemia in type 2 diabetes: A consensus
algorithm for the initiation and adjustment of therapy: A consensus
statement of the American diabetes association and the European
association for the study of diabetes. Diabetes Care. 32:193–203.
2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Faria J, Negalha G, Azevedo A and Martel
F: Metformin and breast cancer: Molecular targets. J Mammary Gland
Biol Neoplasia. 24:111–123. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ala M and Ala M: Metformin for
cardiovascular protection, inflammatory bowel disease,
osteoporosis, periodontitis, polycystic ovarian syndrome,
neurodegeneration, cancer, inflammation and senescence: What is
next? ACS Pharmacol Transl Sci. 4:1747–1770. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cejuela M, Martin-Castillo B, Menendez JA
and Pernas S: Metformin and breast cancer: Where are we now? Int J
Mol Sci. 26(5407)2025.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ahmadpour F, Igder S, Eftekhari Moghadam
AR, Moradipoodeh B, Sepahdar A, Mokarram P, Fallahi J and
Mohammadzadeh G: Metformin as a potential therapeutic agent in
breast cancer: Targeting miR-125a methylation and epigenetic
regulation. Int J Mol Cell Med. 13:272–285. 2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Amaral MEA, Nery LR, Leite CE, de Azevedo
Junior WF and Campos MM: Pre-clinical effects of metformin and
aspirin on the cell lines of different breast cancer subtypes.
Invest New Drugs. 36:782–796. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Huang Y, Zhou Z, Zhang J, Hao Z, He Y, Wu
Z, Song Y, Yuan K, Zheng S, Zhao Q, et al: lncRNA MALAT1
participates in metformin inhibiting the proliferation of breast
cancer cell. J Cell Mol Med. 25:7135–7145. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Alizade A, Evyapan G, Celik IS and Ozdem
B: Metformin induces mitochondria-mediated and endoplasmic
reticulum stress-mediated apoptosis and inhibits
angiogenesis-related gene expression in breast cancer cells via
targeting VEGF-A/VEGFR2/NRP1. Croat Med J. 66:115–124.
2025.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li Y, Zhang Q, Yang J, He W, Jiang Y, Chen
Y and Wang Y: Metformin combined with glucose starvation
synergistically suppress triple-negative breast cancer by enhanced
unfolded protein response. Biochem Biophys Res Commun. 675:146–154.
2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim C and Kim B: . Anti-cancer natural
products and their bioactive compounds inducing ER stress-mediated
apoptosis: A review. Nutrients. 10(1021)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Roshan Moniri M, Young A, Reinheimer K,
Rayat J, Dai LJ and Warnock GL: Dynamic assessment of cell
viability, proliferation and migration using real time cell
analyzer system (RTCA). Cytotechnology. 67:379–386. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Saini N and Yang X: Metformin as an
anti-cancer agent: Actions and mechanisms targeting cancer stem
cells. Acta Biochim Biophys Sin (Shanghai). 50:133–143.
2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen TW, Liang YN, Feng D, Tao LY, Qi K,
Zhang HY, Wang HX, Lin QS and Kong H: Metformin inhibits
proliferation and promotes apoptosis of HER2 positive breast cancer
cells by downregulating HSP90. J BUON. 18:51–56. 2013.PubMed/NCBI
|
|
34
|
Neamati D, Khedri A, Aberomand M, Hemmati
AA, Mohammadzadeh M, Akbari Baghbani K and Mohammadzadeh G:
Metformin synergistically increases the anticancer effects of
lapatinib through induction of apoptosis and modulation of Akt/AMPK
pathway in SK-BR3 breast cancer cell line. Iran J Basic Med Sci.
24:1529–1537. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xu Y, Xu T, Xiong Y and Huang J: Metformin
inhibits proliferation and promotes apoptosis of HER-2 positive
breast cancer cells possibly through the Hippo-YAP pathway. Nan
Fang Yi Ke Da Xue Xue Bao. 42:740–746. 2022.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
36
|
Liu B, Fan Z, Edgerton SM, Yang X, Lind SE
and Thor AD: Potent anti-proliferative effects of metformin on
trastuzumab-resistant breast cancer cells via inhibition of
erbB2/IGF-1 receptor interactions. Cell Cycle. 10:2959–2966.
2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang W, Shi Y, Oyang L, Cui S, Li S, Li
J, Liu L, Li Y, Peng M, Tan S, et al: Endoplasmic reticulum
stress-a key guardian in cancer. Cell Death Discov.
10(343)2024.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Walter P and Ron D: The unfolded protein
response: From stress pathway to homeostatic regulation. Science.
334:1081–1086. 2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yang J, Wei J, Wu Y, Wang Z, Guo Y, Lee P
and Li X: Metformin induces ER stress-dependent apoptosis through
miR-708-5p/NNAT pathway in prostate cancer. Oncogenesis.
4(e158)2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lee DE, Lee GY, Lee HM, Choi SY, Lee SJ
and Kwon OS: Synergistic apoptosis by combination of metformin and
an O-GlcNAcylation inhibitor in colon cancer cells. Cancer Cell
Int. 23(108)2023.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lee DE, Lee HM, Jun Y, Choi SY, Lee SJ and
Kwon OS: Metformin induces apoptosis in TRAIL-resistant colorectal
cancer cells. Biochim Biophys Acta Mol Cell Res.
1872(119873)2025.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ye J, Qi L, Chen K, Li R, Song S, Zhou C
and Zhai W: Metformin induces TPC-1 cell apoptosis through
endoplasmic reticulum stress-associated pathways in vitro and in
vivo. Int J Oncol. 55:331–339. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Dong LR, Li M, Li S, Liu AD, Xiong YJ,
Tang H and Song XD: Metformin induced apoptosis of papillary
thyroid carcinoma BCPAP cells. Lin Chuang Er Bi Yan Hou Tou Jing
Wai Ke Za Zhi. 31:937–940. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
44
|
Conza D, Mirra P, Calì G, Insabato L,
Fiory F, Beguinot F and Ulianich L: Metformin dysregulates the
unfolded protein response and the WNT/β-Catenin pathway in
endometrial cancer cells through an AMPK-Independent mechanism.
Cells. 10(1067)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Leclerc GM, Leclerc GJ, Kuznetsov JN,
DeSalvo J and Barredo JC: Metformin induces apoptosis through
AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts.
PLoS One. 8(e74420)2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wang J, Chen C, Ren Y, Zhou X and Yu S:
Metformin alleviates intestinal epithelial barrier damage by
inhibiting endoplasmic reticulum stress-induced cell apoptosis in
colitis cell model. Zhejiang Da Xue Xue Bao Yi Xue Ban. 50:627–632.
2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
47
|
Kim HI, Lee JS, Kwak BK, Hwang WM, Kim MJ,
Kim YB, Chung SS and Park KS: Metformin ameliorates lipotoxic
β-Cell dysfunction through a concentration-dependent dual mechanism
of action. Diabetes Metab J. 43:854–866. 2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Jin J, Ma Y, Tong X, Yang W, Dai Y, Pan Y,
Ren P, Liu L, Fan HY, Zhang Y and Zhang S: Metformin inhibits
testosterone-induced endoplasmic reticulum stress in ovarian
granulosa cells via inactivation of p38 MAPK. Hum Reprod.
35:1145–1158. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Keshandehghan A, Nikkhah S, Tahermansouri
H, Heidari-Keshel S and Gardaneh M: Co-Treatment with sulforaphane
and nano-metformin molecules accelerates apoptosis in HER2+ breast
cancer cells by inhibiting key molecules. Nutr Cancer. 72:835–848.
2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Stambolic V, Woodgett JR, Fantus IG,
Pritchard KI and Goodwin PJ: Utility of metformin in breast cancer
treatment, is neoangiogenesis a risk factor? Breast Cancer Res
Treat. 114:387–389. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Dowling RJ, Niraula S, Stambolic V and
Goodwin PJ: Metformin in cancer: Translational challenges. J Mol
Endocrinol. 48:R31–R43. 2012.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Morales DR and Morris AD: Metformin in
cancer treatment and prevention. Annu Rev Med. 66:17–29.
2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Quentin T, Steinmetz M, Poppe A and Thoms
S: Metformin differentially activates ER stress signaling pathways
without inducing apoptosis. Dis Model Mech. 5:259–269.
2012.PubMed/NCBI View Article : Google Scholar
|
